Company Filing History:
Years Active: 2008
Title: Pascale Grel: Innovator in GlyT1 Transporter Research
Introduction
Pascale Grel is a notable inventor based in Viry-Chatillon, France. She has made significant contributions to the field of biotechnology, particularly in the study of the GlyT1 transporter. Her work focuses on the development of novel therapeutic approaches for neurological and psychiatric disorders.
Latest Patents
Pascale Grel holds a patent for "Variants and exons of the GlyT1 transporter." This invention provides polypeptide and polynucleotide sequences for novel splice variants of the sodium and chloride-dependent glycine transporter type 1 (GlyT1). These polypeptides and polynucleotides are useful in the treatment and diagnosis of disorders such as schizophrenia. The invention also includes antibodies specifically directed against these novel polypeptides, along with kits comprising the described polynucleotides, polypeptides, and/or antibodies.
Career Highlights
Pascale Grel is associated with Serono Genetics Institute S.A., where she has been instrumental in advancing research related to GlyT1 transporters. Her innovative work has the potential to impact the treatment of various neurological conditions.
Collaborations
Pascale has collaborated with notable colleagues, including Gilbert Thill and Philippe Jais, to further her research and development efforts in the field.
Conclusion
Pascale Grel's contributions to the understanding of GlyT1 transporters highlight her role as an innovator in biotechnology. Her patent and ongoing research efforts are paving the way for new treatments for serious neurological disorders.